Global Continuous Subcutaneous Insulin Infusion Market Size Study by Product, Patient Type, End-Use, and Regional Forecasts 2022-2032

Global Continuous Subcutaneous Insulin Infusion Market Size Study by Product, Patient Type, End-Use, and Regional Forecasts 2022-2032

The Global Continuous Subcutaneous Insulin Infusion Market, valued at approximately USD 0.69 billion in 2023, is poised to grow exponentially, reaching an estimated USD 1.34 billion by 2032, with a compelling CAGR of 9.00% over the forecast period 2024-2032. This growth is primarily attributed to the increasing prevalence of diabetes worldwide, combined with the rising demand for advanced insulin delivery systems that improve glycemic control and enhance patient compliance. The transition toward minimally invasive technologies has underscored the importance of continuous subcutaneous insulin infusion (CSII) systems, which offer precision and adaptability in diabetes management.

CSII systems, encompassing patch pumps and tethered pumps, are revolutionizing the landscape of diabetes care by delivering basal and bolus insulin doses in a controlled manner. Their ability to minimize the challenges associated with traditional insulin therapy methods has significantly enhanced their adoption. Furthermore, technological advancements, such as integration with continuous glucose monitoring (CGM) systems and smartphone connectivity, have positioned these devices as indispensable tools for personalized diabetes management. However, challenges such as high costs and limited access in emerging economies remain pressing concerns, which stakeholders are addressing through strategic pricing models and educational initiatives.

The market's growth trajectory is further bolstered by favorable healthcare policies and increased investments in research and development activities. The rising prevalence of diabetes Type 1, particularly in pediatric and young adult populations, has fueled the demand for user-friendly and compact insulin infusion solutions. Additionally, expanding awareness campaigns emphasizing early diagnosis and effective diabetes management are creating robust growth opportunities across various regions.

Regionally, North America dominates the Continuous Subcutaneous Insulin Infusion Market, underpinned by a strong healthcare infrastructure, high adoption rates of innovative technologies, and a significant patient pool. Europe follows suit, driven by government initiatives promoting diabetes management and the presence of leading market players. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period, attributed to the rising incidence of diabetes, increasing healthcare spending, and growing awareness regarding advanced insulin delivery systems. Latin America and the Middle East & Africa also present promising potential, supported by improving healthcare facilities and heightened focus on diabetes care.

Major market players included in this report are:
• Medtronic plc
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Roche Diabetes Care
• Ypsomed Holding AG
• Sooil Development Co., Ltd.
• Cellnovo Group SA
• Eli Lilly and Company
• Novo Nordisk A/S
• Animas Corporation (Johnson & Johnson)
• Beta Bionics, Inc.
• Valeritas Holdings, Inc.
• Debiotech SA
• Senseonics Holdings, Inc.
• Sanofi

The detailed segments and sub-segment of the market are explained below:

By Product:
• Patch Pumps
• Tethered Pumps

By Patient Type:
• Diabetes Type 1
• Diabetes Type 2

By End-Use:
• Hospitals
• Clinics
• Homecare Settings

By Region:

North America:
• U.S.
• Canada

Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America:
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:
• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level insights across major regions.
• Competitive landscape featuring information on major players and their strategies.
• Analysis of key business strategies and recommendations for future market approaches.
• Comprehensive analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.